Morgan Stanley’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-181,582
| Closed | -$735K | – | 8089 |
|
|
2023
Q4 | $735K | Buy |
181,582
+143,012
| +371% | +$579K | ﹤0.01% | 5450 |
|
|
2023
Q3 | $104K | Sell |
38,570
-1,407
| -4% | -$3.79K | ﹤0.01% | 5875 |
|
|
2023
Q2 | $373K | Sell |
39,977
-1,910
| -5% | -$17.8K | ﹤0.01% | 5364 |
|
|
2023
Q1 | $372K | Buy |
41,887
+30,409
| +265% | +$270K | ﹤0.01% | 5423 |
|
|
2022
Q4 | $57.2K | Buy |
11,478
+2,721
| +31% | +$13.6K | ﹤0.01% | 6235 |
|
|
2022
Q3 | $51K | Sell |
8,757
-3,876
| -31% | -$22.6K | ﹤0.01% | 6401 |
|
|
2022
Q2 | $70K | Buy |
12,633
+2,985
| +31% | +$16.5K | ﹤0.01% | 6451 |
|
|
2022
Q1 | $111K | Sell |
9,648
-31
| -0.3% | -$357 | ﹤0.01% | 6244 |
|
|
2021
Q4 | $123K | Buy |
+9,679
| New | +$123K | ﹤0.01% | 6318 |
|